Orca Bio Patents

Patent portfolio assigned to Orca Bio (verified via public assignee records). Estimated patent count: 36. Clinical-stage allogeneic cell therapy company; no commercial product so no named customers. Competitors only available from aggregator (Growjo), not a primary source. Patents: GreyB/Justia report Orca Biosystems Inc. as assignee (GreyB: ~36 total, 8 granted, hematopoietic cell therapy); Google Patents itself returned 503 on direct fetch so count is aggregator-derived.